✦ LIBER ✦

Preclinical to Clinical Translation of Tofacitinib, a Janus Kinase Inhibitor, in Rheumatoid Arthritis

✍ Scribed by Dowty, M. E.; Jesson, M. I.; Ghosh, S.; Lee, J.; Meyer, D. M.; Krishnaswami, S.; Kishore, N.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tofacitinib: The First Janus Kinase (JAK

✍ Vyas, Deepti (author);O'Dell, Kate M. (author);Bandy, Jason L. (author);Boyce, E 📂 Article 📅 2013 🏛 Harvey Whitney Books Company 🌐 English ⚖ 293 KB

Tofacitinib: The First Janus Kinase (JAK

✍ Vyas, Deepti (author);O'Dell, Kate M. (author);Bandy, Jason L. (author);Boyce, E 📂 Article 📅 2013 🏛 Harvey Whitney Books Company 🌐 English ⚖ 293 KB

The effectiveness of tofacitinib, a nove

✍ Paweł Kawalec, Alicja Mikrut, Natalia Wiśniewska, Andrzej Pilc 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 323 KB

Cardiotoxicity of kinase inhibitors: the

✍ Force, Thomas; Kolaja, Kyle L. 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 468 KB

Effects of the Janus Kinase Inhibitor CP

✍ Fujii, Yasutomo; Sengoku, Takanori 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 581 KB

Erratum to: Tofacitinib: A Review of its

✍ Scott, Lesley J. 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 119 KB